Ramsey Joanne
The School of Law, Stair Building, 5-8 The Square, University of Glasgow G12 8QQ, UK.
Reprod Biomed Online. 2007 Sep;15 Suppl 1:25-33. doi: 10.1016/s1472-6483(10)60355-0.
The Human Fertilisation and Embryology Authority (HFEA) policy on payments to egg donors states that an 'expense neutral' approach is to be adopted, regardless of whether the donation is for treatment or research purposes. In this article the HFEA case against compensatory payments for egg donors will be examined as will the expectation that women should donate eggs for medical research without the offer of financial recompense. This will be shown to sit uneasily alongside existing policy that both permits indirect payments by way of egg-sharing schemes and allows healthy participants in research trials to receive financial remuneration for their contribution to medical science. It will be concluded that the HFEA should reconsider its policy on paying women to donate eggs for medical research.
人类受精与胚胎学管理局(HFEA)关于向卵子捐赠者支付报酬的政策规定,无论捐赠是用于治疗还是研究目的,都应采用“费用中性”的方法。在本文中,将审视HFEA反对向卵子捐赠者支付补偿性报酬的理由,以及期望女性在没有经济补偿的情况下为医学研究捐赠卵子的情况。这将表明,这与现行政策不太协调,现行政策既允许通过卵子共享计划进行间接支付,又允许参与研究试验的健康参与者因其对医学科学的贡献而获得经济报酬。结论是,HFEA应该重新考虑其关于向女性支付报酬以捐赠卵子用于医学研究的政策。